We are live on ! Find out more
APOPW

Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW

Delisted

APOPW was delisted on the 3rd of August, 2021.

Back to rankings

1 hedge funds and large institutions have $1K invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

83% less capital invested

Capital invested by funds: $6K → $1K (-$5K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5K
2
UBS Group
UBS Group
Switzerland
-$450
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1K -$450 -1,402 -33%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
– -$5K -28,500 Closed

APOPW Hedge Fund Activity: Q1 2021 in Review

1 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q1 2021, worth a combined $1K — down 83% from $6K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of APOPW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $5K sold.

  • 1 institutional investor held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q1 2021, down from 2 in Q4 2020.
  • Funds reported $1K of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q1 2021, down 83% quarter-over-quarter.
  • 0 funds opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q1 2021 and 1 closed out, a net change of -1 holder.
  • The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs seller in Q1 2021 was Susquehanna International Group, an estimated $5K sold.

Based on aggregated 13F filings for Q1 2021.